Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.

Objective: To estimate the population pharmacokinetics of theophylline in very premature infants using the non-linear mixed effects modelling. Method: A total of 167 serum concentration measurements obtained from routine theophylline monitoring of 107 very premature Japanese infants were collected....

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Clinical Pharmacy & Therapeutics Vol. 30; no. 6; pp. 591 - 597
Autores principales: Fukuda T, Yukawa E, Kondo G, Maeda T, Shin-O T, Kondo Y, Imamura T, Irikura M, Irie T
Formato: research Journal Article
Publicado: Wiley-Blackwell Dec2005
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106089931&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106089931
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02694727
        EV4
      jtl: Journal of Clinical Pharmacy & Therapeutics
      issn: 02694727
      maglogo: Y
    pubinfo:
      dt: Dec2005
      vid: 30
      iid: 6
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        106089931
        2009422342
        10.1111/j.1365-2710.2005.00689.x
        NLM16336292
        106089931
      ppf: 591
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.
      aug:
        au:
          Fukuda T
          Yukawa E
          Kondo G
          Maeda T
          Shin-O T
          Kondo Y
          Imamura T
          Irikura M
          Irie T
      sug:
        subj:
          Apnea Drug Therapy
          Bronchodilator Agents Pharmacokinetics
          Models, Biological
          Theophylline Pharmacokinetics
          Apnea Metabolism
          Asians
          Bronchodilator Agents Blood
          Bronchodilator Agents Therapeutic Use
          Female
          Infant, Newborn
          Infant, Premature
          Male
          Reproducibility of Results
          Retrospective Design
          Theophylline Blood
          Theophylline Therapeutic Use
          Human
          Infant, Newborn: birth-1 month
          Female
          Male
      ab: Objective: To estimate the population pharmacokinetics of theophylline in very premature infants using the non-linear mixed effects modelling. Method: A total of 167 serum concentration measurements obtained from routine theophylline monitoring of 107 very premature Japanese infants were collected. Results: The final pharmacokinetic parameters were CL (mL/h) = [6·98 · body weight (BW) (kg)2·17 + 0·244 · post-conceptional age (weeks)] · 1·24oxygen support, Vd (L) = 0·492 · BW (kg) and F = 0·660, respectively. Clearance was increased by 24% for patients receiving oxygen support. The inter-individual variabilities in clearance and apparent volume of distribution were 15·6% and 80·4%, respectively, and the residual variability was 34·2% as a coefficient of variation. Conclusion: Application of the findings in this study to patient care may permit selection of an appropriate initial maintenance dosage to achieve target theophylline concentrations, thus enabling the clinician to achieve the desired therapeutic effect in very premature Japanese infants.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N